Search the Newsreel

Carmignac Gestion Cuts Stock Holdings in Colgate-Palmolive Company $CL

Carmignac Gestion significantly reduced its stake in Colgate-Palmolive Company (NYSE:CL) by 79.5% in the first quarter, selling over 900,000 shares. Despite this reduction by one institutional investor, other funds like Teacher Retirement System of Texas and Mirae Asset Global Investments Co. Ltd. increased their …

Colgate-Palmolive Company (CL) PT Raised to $89 at Jefferies

Jefferies analyst Kaumil Gajrawala increased the price target for Colgate-Palmolive Company (NYSE: CL) to $89.00 from $88.00. The analyst maintained a rating on the stock. This article is a premium-only content piece, requiring a subscription to StreetInsider.com Premium to view in full.

Colgate-Palmolive: Base Business EPS Increases 8% As Gross Margin Expands 140 Basis Points

Colgate-Palmolive reported an 8% increase in Base Business EPS for Q2 2026, reaching $0.99, driven by gross margin expansion, organic sales growth, and improved operating profit. This occurred despite a 5% decline in reported EPS due to costs from its Strategic Growth and Productivity …

First Nebraska Trust Co Takes $5.16 Million Position in Colgate-Palmolive Company $CL

First Nebraska Trust Co. has acquired a new stake worth approximately $5.16 million in Colgate-Palmolive Company, purchasing 60,532 shares. This comes as Colgate-Palmolive reported strong Q2 earnings, beating analyst estimates with $0.99 EPS and a 4.9% increase in revenue. Despite positive financial results and …

Colgate-Palmolive (CL) Stock Sees Revenue Strength Clash With Margin Strain

Colgate-Palmolive (CL) is experiencing revenue growth, particularly in premium oral care, pet nutrition, and emerging markets, with Q2 2026 net sales up mid-single digit. However, profitability remains a concern, with a trailing 12-month net margin of 10% compared to 14.5% the previous year, and …

Colgate-Palmolive Company $CL Stock Position Cut by Vestor Capital LLC

Vestor Capital LLC significantly cut its stake in Colgate-Palmolive (CL) by 95.1% in Q1 2026, selling over 30,000 shares but still retaining 1,560 shares. Despite this, other institutional investors increased their positions, and 80.41% of the stock is held by institutions. The article also …

Qué significan para los accionistas la reducción de los márgenes y las previsiones estables de Colgate-Palmolive (CL) para el segundo trimestre de 2026

Was der Margenrückgang im zweiten Quartal 2026 und die unveränderte Prognose von Colgate-Palmolive (CL) für die Aktionäre bedeuten

Colgate Palmolive (CL) Stock Trades At A Cash Flow Discount Despite An Earnings Premium

Colgate-Palmolive (CL) Earnings Keep Fair Value In Focus

XS259833213 Bond Profile — Key Metrics

This article provides key metrics for the Autoliv, Inc. 4.25% 15-MAR-2028 bond, identified by XS259833213, traded on the Munich Stock Exchange. It details the issuer, issue and maturity dates, outstanding amount, face value, minimum denomination, and coupon rate. Autoliv, Inc. is described as a …

What Colgate-Palmolive (CL)'s Q2 2026 Margin Squeeze And Steady Guidance Mean For Shareholders

Colgate-Palmolive reported increased sales in Q2 2026 but experienced a dip in net income and earnings per share due to margin squeeze from rising costs. Despite this, the company maintained its full-year 2026 guidance for 2% to 6% net sales growth and double-digit GAAP …

Colgate-Palmolive Co reports results for the quarter ended June 30 - Earnings Summary

Colgate-Palmolive Co (CL) has released its earnings summary for the quarter that concluded on June 30. The report, sourced from Refinitiv, is available for full viewing to subscribers of TradingView's news services.

Colgate-Palmolive hält an Gewinnprognose für das Gesamtjahr 2026 fest

Colgate-Palmolive reaffirms annual sales forecast on weak North America demand

Colgate-Palmolive affirmed its annual

Colgate-Palmolive (CL) Q2 2026 Earnings

Colgate-Palmolive (CL) reported strong Q2 2026 earnings, beating EPS estimates by 4.5% with $0.99, extending its beat streak to five quarters. The company's revenue of $5.36 billion met expectations, and it saw accelerating volume growth despite a sales decline in North America. Following these …

Colgate-Palmolive (CL) Q2 Earnings and Revenues Top Estimates

Colgate-Palmolive (CL) reported strong Q2 earnings, beating Zacks Consensus Estimates with $0.99 per share and revenues of $5.36 billion. The company has consistently surpassed EPS estimates over the last four quarters and seen its shares gain 15.9% year-to-date, outperforming the S&P 500. While its …

Colgate-Palmolive Sales Rise Despite Choppy Backdrop

Colgate-Palmolive reported increased sales in the second quarter, despite a challenging consumer market. The company's revenue grew by 4.9% to $5.36 billion. However, its profit declined to $693 million, or 86 cents per share, from $743 million, or 91 cents per share, in the …

Colgate-Palmolive tops EPS estimates, but shares dip

Colgate-Palmolive (NYSE:CL) reported second-quarter earnings that surpassed analyst expectations, with adjusted EPS of $0.99 against an estimate of $0.95. Revenue matched consensus at $5.36 billion, marking a 4.9% increase year-over-year. Despite these positive results and an increase in advertising spend, the company's shares experienced …

Colgate-Palmolive supera las estimativas de BPA, pero sus acciones caen

Colgate-Palmolive (NYSE:CL) Posts Q2 CY2026 Sales In Line With Estimates

Colgate-Palmolive (NYSE:CL) reported Q2 CY2026 results, with sales growing 4.9% year-on-year to $5.36 billion, meeting Wall Street estimates. The company's non-GAAP profit per share of $0.99 exceeded analyst expectations by 4.5%. Despite strong financial performance and organic revenue growth in several divisions, the company's …

Colgate-Palmolive superaron 0.04$ las previsiones de BPA en el segundo trimestre del año

Colgate-Palmolive supera por 0,04$ las previsiones de BPA en el segundo trimestre del año

Colgate keeps 2026 sales outlook, lifts non-GAAP EPS growth

Colgate-Palmolive (NYSE: CL) announced its second-quarter 2026 results, showing a 4.9% increase in net sales and a 2.4% organic sales growth, despite a 5% GAAP EPS decrease. The company maintained its full-year 2026 net sales and GAAP EPS guidance but upgraded its non-GAAP (Base …

Colgate-Palmolive (CL) Tops Q2 EPS by 4c; Offers Guidance

Colgate-Palmolive (CL) reported strong Q2 earnings, surpassing analyst estimates by $0.04 with an EPS of $0.99 and meeting revenue expectations at $5.36 billion. The company also provided its full-year 2026 guidance, expecting net sales to be up 2% to 6% and organic sales growth …

Colgate-Palmolive Company $CL Shares Sold by South Dakota Investment Council

The South Dakota Investment Council reduced its stake in Colgate-Palmolive Company (NYSE:CL) by 29.2% in the first quarter, selling over 31,000 shares but retaining 76,661 shares valued at $6.5 million. Despite this institutional selling, analysts generally maintain a "Moderate Buy" rating with an average …

Groupe la Francaise Boosts Stock Holdings in Colgate-Palmolive Company $CL

Groupe la Francaise significantly increased its stake in Colgate-Palmolive Company (NYSE:CL) by 295.3% in the first quarter, now owning 138,723 shares valued at $11.666 million. Other institutional investors like Norges Bank and Bank of New York Mellon Corp also adjusted their holdings. The article …

Colgate-Palmolive Company $CL Shares Sold by Empowered Funds LLC

Empowered Funds LLC reduced its stake in Colgate-Palmolive Company (NYSE:CL) by 21.2% in the first quarter, selling 35,005 shares and bringing its total holdings to 130,068 shares valued at $11.086 million. Despite this, other institutional investors like Quantinno Capital Management LP and Lazard Asset …

Colgate-Palmolive Lifts FY26 Adj. Earnings View, Despite Weak Q2 Profit; Stock Down

Colgate-Palmolive reported a weak Q2 profit despite higher net sales but confirmed its fiscal 2026 outlook for earnings and sales growth, while lifting guidance for Base Business earnings per share and gross profit margin. The company's shares were down approximately 2.78% in pre-market trading. …

Colgate-Palmolive falls after reporting soft organic sales in North America (CL:NYSE)

Colgate-Palmolive (CL) shares declined after its Q2 earnings report revealed a 4.9% revenue increase to $5.36 billion. However, organic sales growth was a softer 2.4%, impacted negatively by lower private label pet food sales. The report indicated some softness in North American organic sales.

Colgate-Palmolive supera estimativas de LPA, mas ações recuam - Investing.com Brasil

Colgate-Palmolive Aktie: Zahlen schlagen, Kurs fällt

Colgate-Palmolive Q2 Earnings Call Highlights

Colgate-Palmolive (CL) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Top Wall Street Forecasters Revamp Colgate-Palmolive Expectations Ahead Of Q2 Earnings

Ahead of its Q2 earnings report on Friday, July 31, Colgate-Palmolive (NYSE: CL) is expected to report quarterly earnings of 95 cents per share and revenue of $5.36 billion. Several Wall Street analysts have recently updated their ratings and price targets for the company, …

Colgate earnings up next: Can premium products lift margins? By Investing.com

Colgate-Palmolive (CL) is set to report its second-quarter earnings, with analysts expecting $0.95 EPS and $5.36 billion in revenue. Investors will focus on the company's ability to drive margins through premium products and manage volume versus pricing dynamics, especially after a strong first quarter. …